Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant Redazione 20 Maggio 2021 ...
Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia Redazione 13 Maggio 2021 ...
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia Redazione 13 Maggio 2021 ...
Phase 1b trial of isatuximab, an anti‐CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma Redazione 13 Maggio 2021 ...
Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant Redazione 13 Maggio 2021 ...
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score Redazione 6 Maggio 2021 ...